SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,146,000 | +8.0% | 121,295 | +2.4% | 0.26% | +31.3% |
| Q2 2020 | $1,061,000 | +29.4% | 118,401 | -10.3% | 0.20% | +12.9% |
| Q1 2020 | $820,000 | +39.0% | 132,021 | +86.5% | 0.18% | +50.8% |
| Q4 2019 | $590,000 | -5.3% | 70,777 | +2.8% | 0.12% | -17.5% |
| Q3 2019 | $623,000 | -15.4% | 68,869 | 0.0% | 0.14% | -12.3% |
| Q2 2019 | $736,000 | +9.0% | 68,869 | -2.7% | 0.16% | -1.8% |
| Q1 2019 | $675,000 | +17.8% | 70,800 | +42.0% | 0.17% | +2.5% |
| Q4 2018 | $573,000 | -34.6% | 49,870 | -3.5% | 0.16% | -22.9% |
| Q3 2018 | $876,000 | +54.2% | 51,680 | +29.2% | 0.21% | +44.8% |
| Q2 2018 | $568,000 | – | 40,013 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |